Requires insurers to provide information on resources for insureds or enrollees recently diagnosed with Alzheimer's disease.
Summary
Bill A03538 mandates that insurers in New York provide written informational resources to insureds or enrollees who have recently been diagnosed with Alzheimer's disease. The bill requires that these resources be sent within sixty days of notification of the diagnosis, either through claims data or directly from the insured or enrollee. The information must be evidence-based, culturally and linguistically appropriate, and developed by medical and disability experts. Additionally, the bill stipulates that contact information for organizations specializing in Alzheimer's support, such as the Alzheimer's Association, must be included in the resources provided.
Impact
If enacted, this bill would amend the New York insurance law to include a new requirement for insurers, health maintenance organizations, and corporations providing accident and health insurance. It would enhance the support available to individuals diagnosed with Alzheimer's disease by ensuring they receive timely and relevant information about their condition and available resources, thereby potentially improving their quality of care and support.
Sentiment
The sentiment surrounding Bill A03538 appears to be positive, as it addresses a critical need for support and information for individuals diagnosed with Alzheimer's disease. Discussions indicate a recognition of the importance of providing resources to assist patients and their families during a challenging time, although specific voting history and committee discussions are not available to gauge opposition or concerns.
Contention
While there are no recorded votes or committee discussions available to highlight specific points of contention, potential concerns may arise regarding the implementation of the bill, such as the costs associated with providing these resources and the logistics of ensuring compliance by insurers. Stakeholders may have differing views on the sufficiency of the information provided and the effectiveness of the mandated notification process.
Requires insurers to provide insurance coverage for treatment of rare diseases, life-threatening conditions or diseases, degenerative and disabling conditions, or diagnoses involving medically fragile children, by a provider of the patient's choice.